What does PAEPSEM do?

PAEPSEM is a property company in Gent. Public Limited, started on 28 September 1993, 1 establishment.

What is the address of PAEPSEM?

The registered office of PAEPSEM is located at Zuiderlaan 1-3 box 1, 9000 Gent.

Is PAEPSEM still active?

Yes. According to the CBE (29 October 2026) PAEPSEM is active, legal situation “Normale toestand”, started on 28 September 1993.

Is PAEPSEM registered on Peppol?

Yes, PAEPSEM is registered on the Peppol network with ID 0208:0450972301.

What is the enterprise number of PAEPSEM?

The enterprise number of PAEPSEM is BE0450972301.

When was PAEPSEM founded?

PAEPSEM was founded on 28 September 1993.

Who are the directors of PAEPSEM?

According to the 2025 annual accounts, the directors of PAEPSEM are: License to Construct.

Is PAEPSEM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 September 1993; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PAEPSEM make in 2025?

PAEPSEM recorded a loss after taxes of € 796,527 in financial year 2025.

What is the revenue of PAEPSEM?

In its most recent annual accounts (2025), PAEPSEM reported revenue of € 788,648.

Does PAEPSEM have a website?

Yes, PAEPSEM has a website at respireclinic.be.

PAEPSEM (Public Limited) - Gent - BE0450972301

Dossier PAEPSEM, printed on 29 October 2026 from databakkes.be/en/0450972301/paepsem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Busy address KBO

20 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

PAEPSEM from Gent, company number BE0450972301, closed financial year 2025 with a result of € -796,527 after tax. For that financial year PAEPSEM recorded revenue of € 788,648 and equity of € 7.9 million. Compared with financial year 2024, the result moved from € -463,907 to € -796,527. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Healthy

€ 7.9 million

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -796,527

▼ 72 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 38,862

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -1.8 million.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 4.4 million

▼ 3% vs 2024

€ 367,323 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 805,072

▲ 79% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	€ 1,173,880 Revenue 2023: € 1,173,880 First fiscal year in the series	€ 771,360 Revenue 2024: € 771,360 ▼ 34% vs 2023 (€ 1,173,880) Unfavourable step	€ 788,648 Revenue 2025: € 788,648 ▲ 2% vs 2024 (€ 771,360) Favourable step	▲ 2%
Gross margin	€ 849,070 Gross margin 2022: € 849,070 First fiscal year in the series	€ 852,632 Gross margin 2023: € 852,632 Unchanged (€ 849,070) Favourable step	€ 542,141 Gross margin 2024: € 542,141 ▼ 36% vs 2023 (€ 852,632) Unfavourable step	€ 409,495 Gross margin 2025: € 409,495 ▼ 24% vs 2024 (€ 542,141) Unfavourable step	▼ 24%
Profit after taxes	€ 95,733 Profit after taxes 2022: € 95,733 First fiscal year in the series	€ -6,187 Profit after taxes 2023: € -6,187 ▼ € 101,920 vs 2022 (€ 95,733) Unfavourable step	€ -463,907 Profit after taxes 2024: € -463,907 ▼ € 457,720 vs 2023 (€ -6,187) Unfavourable step	€ -796,527 Profit after taxes 2025: € -796,527 ▼ € 332,620 vs 2024 (€ -463,907) Unfavourable step	▼ € 332,620
Equity	€ 10,217,984 Equity 2022: € 10,217,984 First fiscal year in the series	€ 10,040,234 Equity 2023: € 10,040,234 ▼ 2% vs 2022 (€ 10,217,984) Unfavourable step	€ 8,978,342 Equity 2024: € 8,978,342 ▼ 11% vs 2023 (€ 10,040,234) Unfavourable step	€ 7,888,025 Equity 2025: € 7,888,025 ▼ 12% vs 2024 (€ 8,978,342) Unfavourable step	▼ 12%
Total debts	€ 5,340,839 Total debts 2022: € 5,340,839 First fiscal year in the series	€ 4,675,266 Total debts 2023: € 4,675,266 ▼ 12% vs 2022 (€ 5,340,839) Favourable step	€ 4,963,267 Total debts 2024: € 4,963,267 ▲ 6% vs 2023 (€ 4,675,266) Unfavourable step	€ 5,216,630 Total debts 2025: € 5,216,630 ▲ 5% vs 2024 (€ 4,963,267) Unfavourable step	▲ 5%
Cash	€ 52,590 Cash 2022: € 52,590 First fiscal year in the series	€ 15,842 Cash 2023: € 15,842 ▼ 70% vs 2022 (€ 52,590) Unfavourable step	-	€ 38,862 Cash 2025: € 38,862 First fiscal year in the series
Land & buildings	€ 13,268,245 Land & buildings 2022: € 13,268,245 First fiscal year in the series	€ 12,647,664 Land & buildings 2023: € 12,647,664 ▼ 5% vs 2022 (€ 13,268,245) Unchanged	€ 11,620,314 Land & buildings 2024: € 11,620,314 ▼ 8% vs 2023 (€ 12,647,664) Unchanged	€ 10,834,454 Land & buildings 2025: € 10,834,454 ▼ 7% vs 2024 (€ 11,620,314) Unchanged	▼ 7%
Retained profit	€ -1,296,873 Retained profit 2022: € -1,296,873 First fiscal year in the series	€ -1,060,093 Retained profit 2023: € -1,060,093 ▲ € 236,779 vs 2022 (€ -1,296,873) Favourable step	€ -1,300,686 Retained profit 2024: € -1,300,686 ▼ € 240,592 vs 2023 (€ -1,060,093) Unfavourable step	€ -1,828,694 Retained profit 2025: € -1,828,694 ▼ € 528,008 vs 2024 (€ -1,300,686) Unfavourable step	▼ € 528,008
Bank debt	€ 5,194,157 Bank debt 2022: € 5,194,157 First fiscal year in the series	€ 4,576,603 Bank debt 2023: € 4,576,603 ▼ 12% vs 2022 (€ 5,194,157) Favourable step	€ 4,509,772 Bank debt 2024: € 4,509,772 ▼ 1% vs 2023 (€ 4,576,603) Favourable step	€ 4,354,747 Bank debt 2025: € 4,354,747 ▼ 3% vs 2024 (€ 4,509,772) Favourable step	▼ 3%
Balance sheet total	€ 15,558,822 Balance sheet total 2022: € 15,558,822 First fiscal year in the series	€ 14,725,500 Balance sheet total 2023: € 14,725,500 ▼ 5% vs 2022 (€ 15,558,822) Unchanged	€ 14,159,821 Balance sheet total 2024: € 14,159,821 ▼ 4% vs 2023 (€ 14,725,500) Unchanged	€ 13,651,904 Balance sheet total 2025: € 13,651,904 ▼ 4% vs 2024 (€ 14,159,821) Unchanged	▼ 4%

Key figures of PAEPSEM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PAEPSEM?

What happened at PAEPSEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 16, 2026 New annual accounts for financial year 2025: loss of € 796,527. Source: NBB ↗
2020 License to Construct became a director. NBB
Nov 8, 1993 New establishment in Gent. KBO
Sep 28, 1993 Start of the company according to the CBE. KBO

In short

From € 95,733 profit in 2022 to € 796,527 loss in 2025.

Best year ever: 2022, with € 95,733 profit.

Original PDFs at the National Bank ↗

Management

License to Construct 100%

PAEPSEM

Behind PAEPSEM is License to Construct. The shares are held by License to Construct (100%).

Directors

According to the 2025 annual accounts

License to Construct

Director · represented by Gaëtan Vermeire

Also active at: DE COLVENAER, KONTICH GROND, FIT CAPITAL PARTNERS, KONTICH LEASEHOLD

since 2020

Shareholders

License to Construct

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Zuiderlaan 1-3 box 1

9000 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.

All companies at this address →

DE COLVENAER same network

€ 126,511 revenue · 2025

remedent

€ 62,168 revenue · 2025

Condor Technologies

€ 2,092 revenue · 2025

Pexip Belgium

€ 1.4 million gross margin · 2025

Biotech Dental Benelux

€ 175,643 gross margin · 2025

+15 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS respireclinic.be

Canonical: https://www.respireclinic.be/

Technologies

Contact Form 7CookieYesGoogle AnalyticsNginxPHPWordPressYoast SEOlazysizesreCAPTCHA

Certifications & Partners

RIZIV

Hosting & Email

Email provider

Microsoft 365

Hosting

GOOGLE-CLOUD-PLATFORM - Google LLC, US

Website info

HTTPS Ja

Languages NL

Features

Webshop

Security

✓ HTTPS

✓ SPF

✗ DMARC

Details

Company number

0450.972.301

VAT number

BE 0450.972.301

Registered office

Zuiderlaan 1-3 bus 1, 9000 Gent

Names & denominations

PAEPSEM

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

28 September 1993

Peppol

Active · Active since 20 Nov 2020

Contact

respireclinic.be

Activities · NACE

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

Verhuur en exploitatie van terreinen

View on CBE Public ↗ Annual accounts (NBB) ↗

PAEPSEM

Warning lights

Financials

What happened to PAEPSEM?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Certifications & Partners

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions